Nathalie Worp

Resolving Chemical Modifications to a Single Amino Acid within a Peptide Using a Biological Nanopore

C. Dekker, C. Joo, R. Eelkema, 2019, ACS nano.

An early warning system for emerging SARS-CoV-2 variants

M. Koopmans, L. Abu-Raddad, E. Volz, 2022, Nature Medicine.

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person

M. Koopmans, C. Geurtsvankessel, Marjan Boter, 2022, Emerging infectious diseases.

Identification of mutations in SARS-CoV-2 PCR primer regions

Carla A. Cummins, G. Cochrane, M. Koopmans, 2022, Scientific Reports.

Microcalorimetry: A Novel Application to Measure In Vitro Phage Susceptibility of Staphylococcus aureus in Human Serum

M. Koopmans, M. Graaf, W. V. van Wamel, 2022, Viruses.

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology

M. Koopmans, R. Fouchier, B. O. Oude Munnink, 2021, Nature Medicine.

GPCRmd uncovers the dynamics of the 3D-GPCRome

Toni Giorgino, Gianni De Fabritiis, David E. Gloriam, 2019, bioRxiv.

Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses

Carla A. Cummins, Peter W. Harrison, R. Leinonen, 2023, bioRxiv.

Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variants.

M. Perkins, M. Koopmans, M. V. Van Kerkhove, 2023, The Lancet. Microbe.

Identification of mutations in SARS-CoV-2 PCR primer regions

Carla A. Cummins, G. Cochrane, M. Koopmans, 2022, Scientific Reports.

Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study

H. Bax, B. O. Oude Munnink, C. Geurtsvankessel, 2024, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.